KEGG icon

Drug interaction list


Query:
D08508  Sarpogrelate (INN)

Interactions: 57 hits    [ ATC classification | Therapeutic category ]

D00211  Rifampin (USP); Rifampicin (JP17/INN); Rifadin (TN); Rimactane (TN) (P) CYP induction: CYP3A4
D00276  Clarithromycin (JP17/USP/INN); CAM; Biaxin (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4
D00420  Mitotane (JAN/USP/INN); Lysodren (TN) (P) unclassified
D00506  Phenobarbital (JP17/USP/INN); Luminal (TN) (P) unclassified
D00512  Phenytoin (JP17/USP/INN); Dilantin (TN) (P) Enzyme: CYP2C9 / CYP induction: CYP2B6
D00550  Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) (P) Enzyme: CYP3A4
D00636  Amiodarone hydrochloride (JP17/USP); Ancaron (TN); Cordarone (TN); Nexterone (TN) (P) Enzyme: CYP3A4
D00701  Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) (P) unclassified
D00831  Mefloquine hydrochloride (JP17/USP); Lariam (TN) (P) unclassified
D00961  Bicalutamide (JAN/USP/INN); Casodex (TN) (P) unclassified
D01253  Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) (P) Enzyme: CYP3A4 CYP2C19
D01276  Atazanavir sulfate (JAN/USAN); Reyataz (TN) (P) unclassified
D01832  Modafinil (JAN/USP/INN); Provigil (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP2C9 CYP2C19 / CYP induction: CYP1A2 CYP2B6 CYP3A4
D01855  Mozavaptane hydrochloride (JAN) (P) Enzyme: CYP3A4
D02103  Phenytoin sodium (USP); Phenytoin sodium for injection (JP17); Aleviatin (TN); Dilantin (TN) (P) Enzyme: CYP2C9 / CYP induction: CYP2B6
D02372  Perospirone hydrochloride hydrate (JAN); Lullan (TN) (P) Target: HTR2A
D02484  Artemether and lumefantrine; Coartem (TN) (P) unclassified
D02691  Somatropin (USP/INN); Somatropin (genetical recombination) (JAN); Human growth hormone (JAN); Asellacrin (TN); Nutropin (TN); Omnitrope (TN) (P) unclassified
D02732  Pranlukast hydrate (JP17); Onon (TN) (P) Enzyme: CYP3A4
D02748  Peginterferon alfa-2b (USAN/INN); Peginterferon alfa-2b (genetical recombination) (JAN); Pegintron (TN); Sylatron (TN) (P) unclassified
D02867  Fosamprenavir calcium hydrate (JAN); Lexiva (TN) (CI) Enzyme: CYP3A4 / CYP inhibition: CYP3A4
D02968  Aprepitant (JAN/USP/INN); Emend (TN); Cinvanti (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 CYP2C9
D03106  Bexarotene (JAN/USAN/INN); Targretin (TN) (P) unclassified
D03669  Deferasirox (JAN/USAN/INN); Exjade (TN); Jadenu (TN) (P) CYP inhibition: CYP1A2 / CYP induction: CYP3A4
D04024  Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) (P) Enzyme: CYP3A4
D04059  Mepenzolate bromide and phenobarbital; Trancolon P (TN) (P) unclassified
D04307  Proxyphylline, ephedrine hydrochloride and phenobarbital; Asthmolysin D (TN) (P) unclassified
D04641  Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4
D04666  Lanreotide acetate (JAN/USAN); Somatuline (TN) (P) unclassified
D05177  Nitisinone (JAN/USAN/INN); Orfadin (TN) (P) unclassified
D05775  Rufinamide (JAN/USP/INN); Banzel (TN) (P) unclassified
D06413  Nilotinib hydrochloride hydrate (JAN); Tasigna (TN) (P) Enzyme: CYP3A4
D06414  Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN) (P) Enzyme: CYP3A4
D06597  Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 CYP2C9
D07583  Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) (P) Enzyme: CYP2C9 / CYP induction: CYP2B6
D07595  Fosphenytoin sodium hydrate (JAN); Fostoin (TN) (P) Enzyme: CYP2C9 / CYP induction: CYP3A4 CYP2B6
D09535  Mirabegron (USAN/JAN); Myrbetriq (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP2D6
D09638  Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) (P) Enzyme: CYP3A4
D09701  Abiraterone acetate (JAN/USP); Zytiga (TN) (P) Enzyme: CYP3A4
D09731  Crizotinib (JAN/USAN/INN); Xalkori (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP2B6
D09894  Eliglustat tartrate (JAN/USAN); Eliglustat hemitartrate; Cerdelga (TN) (P) Enzyme: CYP2D6
D09996  Vemurafenib (JAN/USAN/INN); Zelboraf (TN) (P) unclassified
D10003  Hemin (JAN); Normosang (TN) (P) unclassified
D10019  Panobinostat lactate (JAN); Farydak (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP2D6
D10104  Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) (P) Enzyme: CYP3A4 / CYP induction: CYP3A4 CYP2C9
D10161  Sarilumab (USAN); Sarilumab (genetical receombination) (JAN); Kevzara (TN) (P) unclassified
D10218  Enzalutamide (JAN/USAN); Xtandi (TN) (P) unclassified
D10372  Palbociclib (JAN/USAN); Ibrance (TN) (P) unclassified
D10514  Dacomitinib (USAN); Dacomitinib hydrate (JAN); Vizimpro (TN) (P) unclassified
D10551  Ceritinib (JAN/USAN/INN); Zykadia (TN) (P) unclassified
D10564  Amenamevir (JAN/INN); Amenalief (TN) (P) CYP induction: CYP2B6
D10566  Pasireotide pamoate (JAN); Signifor lar (TN) (P) unclassified
D10762  Fosravuconazole L-lysine ethanolate (JAN) (P) unclassified
D10801  Letermovir (JAN/USAN/INN); Prevymis (TN) (P) CYP induction: CYP2C9 CYP2C19
D10926  Entrectinib (JAN/USAN/INN); Rozlytrek (TN) (P) Enzyme: CYP3A4
D11012  Lorlatinib (JAN/USAN/INN); Lorbrena (TN) (P) unclassified
D11040  Apalutamide (JAN/INN); Erleada (TN) (P) Enzyme: CYP3A4 / CYP induction: CYP3A4 CYP2C19